Themis Medicare posts Q2 FY24 PAT at Rs. 11.31 Cr
The company has reported total income of Rs. 107.22 crores during the period ended September 30, 2023
The company has reported total income of Rs. 107.22 crores during the period ended September 30, 2023
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Lyka Labs has reported total income of Rs. 28.23 crores during the period ended September 30, 2023
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
The initiative will focus on advocating for cleaner air
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
The companies plan to start a pivotal Phase 3 trial in the coming months
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening
Subscribe To Our Newsletter & Stay Updated